Complete Up To Date Information about PrednisTab .
NADA Number: 140-921 | |
| Proprietary Name |
PrednisTab® |
|---|---|
| Sponsor |
Lloyd, Inc. |
| Sponsor Address |
604 W. Thomas Ave. Shenandoah, IA 51601 USA |
| Ingredients |
Prednisolone |
| Species |
Dog, restricted during pregnancy |
| Routes of Administration |
Per Os |
| Dose Form |
Tablet |
| Drug Form |
Tablet |
| Dispensing Status |
RX |
|
Dosage Amount, Indications & Limitations |
520.1880 Prednisolone tablets. Specifications: Each tablet contains 5 milligrams prednisolene. Conditions of use: Dogs Amount: Dogs: 2.5 milligrams per 4.5 kilograms (10 pounds) body weight per day. Administer total daily dose orally in equally divided doses 6 to 10 hours apart until response is noted or 7 days have elapsed. When response is attained, dosage should be gradually reduced until maintenance level is achieved. Indications: For use as an anti-inflammatory agent. Limitations: Federal law restricts this drug to use by or on the order of a licensed veterinarian. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate parturition followed by dystocia, fetal death, retained placenta, and metritis. Do not use in viral infections. Systemic therapy with prednisolone is contraindicated in animals with peptic ulcer, corneal ulcer, and Cushingoid syndrome. The presence of diabetes, osteoporosis, predisposition to thrombophlebitis hypertension, congestive heart failure, renal insufficiency and active tuberculosis necessitates carefully controlled use. Some of the above conditions occur only rarely in dogs but should be kept in mind. Anti-inflammatory action of corticosteroids may mask signs of infection. |
| Tolerances |
A tolerance of zero is established for residues of prednisolone in milk from dairy animals. |